Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health
Bob Herman

What's at stake in the $17 billion Oklahoma opioids trial

Oxycontin pills. Photo: Lawrence K. Ho/Los Angeles Times via Getty Images

After Oklahoma's Attorney General Mike Hunter announced an $85 million settlement with Teva Pharmaceuticals over the weekend in the state's ongoing opioids case, only Johnson & Johnson is left defending itself in the suit.

Why it matters: Oklahoma is seeking $17 billion in damages over a crisis that has killed thousands of Americans, and if the state wins, it spells trouble of historic proportions for all of the various companies that are part of the consolidated national lawsuit in Ohio.


  • Purdue Pharma got out of the case by agreeing to a $270 million settlement in March.

Who we're watching: Judge Thad Balkman, who will rule on the case after hearing 8 weeks of arguments.

  • J&J denies wrongdoing and believe Oklahoma’s sole "public nuisance" claim is baseless.

Go deeper: Oklahoma argues J&J was the "kingpin" that fueled the country's opioid crisis

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.